Abstract 4260: PT886, an anti-claudin18.2/anti-CD47 bispecific antibody constructed with the PACbody and SPECpair technology platforms, exhibits robust anti-tumor activity in a pancreatic cancer xenograft model

Jack Li(FibroGen (United States)), Hui Zou, Erin Ramsey, Ming Wang(Wenzhou Medical University), Haiqun Jia, Albert Lam, Hui‐Wen Wu, Kelan Chen(Clover Biopharmaceuticals (China))
Cancer Research
June 15, 2022
Cited by 7


Related Papers